Methods of cardiovascular imaging for the detection of ischemic heart disease

Cover Page

Cite item

Full Text

Abstract

This article is devoted to the role of the modern methods of cardiovascular imaging in the diagnosis of ischemic heart disease (IHD). Stress echocardiography, multislice computed tomography, magnetic resonance imaging and methods of nuclear cardiology have a high sensitivity and specificity in the verification of IHD. They are recommended for patients with intermediate pretest probability of IHD based on the evaluation of clinical symptoms and risk factors. Additionally, in patients with ischemic heart disease modern imaging techniques are useful for evaluation of myocardial viability.

About the authors

V. S Nikiforov

I.I.Mechnikov State Northwestern Medical University of the Ministry of Health of the Russian Federation

Email: viktor.nikiforov@szgmu.ru
д-р мед. наук, проф. каф. функциональной диагностики ФГБОУ ВО «СЗГМУ им. И.И.Мечникова» 191015, Russian Federation, Saint Petersburg, ul. Kirochnaia, d. 41

References

  1. Болезни сердца по Браунвальду. Руководство по сердечно - сосудистой медицине. Под ред. П.Либби. В 4 т. Т. 1. М.: Рид Элсивер, 2010.
  2. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013; 34 (38): 2949-3003.
  3. Achenbach S, Dilsizian V, Kramer C.M, Zoghbi W.A. The year in coronary artery disease. JACC Cardiovasc Imaging 2009; 2 (6): 774-86.
  4. Lancellotti P, Płońska-Gościniak E, Garbi M et al. Cardiovascular imaging practice in Europe: a report from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16 (7): 697-702.
  5. Fraser A.G, Buser P.T, Bax J.J et al. The future of cardiovascular imaging and non - invasive diagnosis: a joint statement from the European Association of Echocardiography, the Working Groups on Cardiovascular Magnetic Resonance, Computers in Cardiology, and Nuclear Cardiology, of the European Society of Cardiology, the European Association of Nuclear Medicine, and the Association for European Paediatric Cardiology. Eur Heart J 2006; 27 (14): 1750-3.
  6. Nicholls S.J, Andrews J, Puri R et al. Imaging progression of coronary atherosclerosis. Circ J 2013; 77 (1): 3-10.
  7. Никифоров В.С., Никитин А.Э., Тыренко В.В., Свистов А.С. Ишемическая дисфункция миокарда. М.: АПКиППРО. 2005.
  8. Garcia M.J. Cardiac CT for CAD. Do we still need angiography? J Cardiovasc Surg (Torino) 2009; 50 (1): 7-17.
  9. Mark D.B, Shaw L.J, Lauer M.S et al. 34th Bethesda Conference: Task force #5 - Is atherosclerosis imaging cost effective? J Am Coll Cardiol 2003; 41 (11): 1906-17.
  10. Архипова И.М., Мершина Е.А., Синицын В.Е. Роль КТ-коронарографии в диагностике ИБС на амбулаторном этапе. Поликлиника. 2013; 3-1: 18-21.
  11. Sun Z, Moudi M, Cao Y. CT angiography in the diagnosis of cardiovascular disease: a transformation in cardiovascular CT practice. Quant Imaging Med Surg 2014; 4 (5): 376-96.
  12. Greenland P, Bonow R.O, Brundage B.H et al. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation 2007; 115 (3): 402-26.
  13. Marwan M, Ropers D, Pflederer T et al. Clinical characteristics of patients with obstructive coronary lesions in the absence of coronary calcification: an evaluation by coronary CT angiography. Heart 2009; 95: 1056-60.
  14. Терновой С.К., Никонова М.Э., Акчурин Р.С. и др. Возможности мультиспиральной компьютерной томографии (МСКТ) в оценке коронарного русла и вентрикулографии в сравнении с интервенционной коронаровентрикулографией. Рос. электронный журн. лучевой диагностики. 2013; 3 (1): 28-36.
  15. Abbara S, Arbab-Zadeh A, Callister T.Q et al. SCCT guidelines for performance of coronary computed tomographic angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 2009; 3: 190-204.
  16. Vavere A.L, Arbab-Zadeh A, Rochitte C.E et al. Coronary artery stenoses: accuracy of 64-detector row CT angiography in segments with mild, moderate, or severe calcification: a subanalysis of the CORE-64trial.Radiology 2011; 261: 100-8.
  17. Nesto R.W, Kowalchuk G.J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987; 59 (7): 23C-30C.
  18. Hyodo E, Muro T, Hozumi T et al. Observation of the ischemic cascade in humans using contrast echocardiography during dobutamine stress. Circ J 2003; 67 (5): 406-10.
  19. Charoenpanichkit C, Hundley W.G. The 20 year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010; 12: 59.
  20. Mieres J.H, Makaryus A.N, Redberg R.F, Shaw L.J. Noninvasive cardiac imaging. Am Fam Physician 2007; 75 (8): 1219-28.
  21. Захарова А.И., Никифоров В.С., Свистов А.С. Диагностические возможности эхокардиографии у больных ишемической болезнью сердца. Регионарн. кровообращение и микроциркуляция. 2007; 6 (4): 78-85.
  22. Lang R.M, Badano L.P, Mor-Avi V et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2015; 16 (3): 233-70.
  23. Шевченко Ю.Л., Бобров Л.Л., Обрезан А.Г., Никифоров В.С. Некоторые гемодинамические эффекты коррекции ишемии миокарда методом хирургической реваскуляризации. Кардиология. 2001; 41 (7): 20-3.
  24. Pellikka P.A, Nagueh S.F, Elhendy A.A et al. American Society of Echocardiography recommendations for performance, interpretation, and application of stress echocardiography. J Am Soc Echocardiogr 2007; 20 (9): 1021-41.
  25. Сергиенко В.Б., Аншелес А.А., Шульгин Д.Н. и др. Методические рекомендации. Перфузионная сцинтиграфия и ОЭКТ миокарда. Кардиол. вестн. 2015; 10 (2): 6-21
  26. Саидова М.А. Стресс - эхокардиография с добутамином: возможности клинического применения в кардиологической практике. Рацион. фармакотерапия в кардиологии. 2009; 5 (4): 73-9.
  27. Бузиашвили Ю.И., Аязян Э.А., Мацкеплишвили С.Т. и др. Контрастная эхокардиография и ее возможности в диагностике ишемической болезни сердца. Бюл. НЦССХ им. А.Н.Бакулева РАМН. Сердечно - сосудистые заболевания. 2004; 5 (9): 71-6.
  28. Senior R, Becher H, Monaghan M et al. Contrast echocardiography: evidence - based recommendations by European Association of Echocardiography. Eur J Echocardiogr 2009; 10: 194-212.
  29. Plana J.C, Mikati I.A, Dokainish H et al. A randomized cross - overstudy for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial. JACC Cardiovasc Imaging 2008; 1: 145-52.
  30. Никифоров В.С., Тютин А.Р., Палагутин М.А. и др. Неинвазивная оценка гемодинамики с помощью тканевой допплерографии. Регионарн. кровообращение и микроциркуляция. 2011; 10 (2): 13-18.
  31. Павлюкова Е.Н., Егорова В.Ю. Анализ деформации миокарда в режиме strain и strain rate при стресс - эхокардиографии с добутамином в зависимости от степени стеноза коронарных артерий. Сиб. мед. журн. 2008; 23 (4-2): 7-10.
  32. Васюк Ю.А., Копелева М.В., Хадзегова А.Б. Оценка локальной сократимости миокарда левого желудочка методом тканевой допплерографии у больных с различными формами ишемической болезни сердца. SonoAce - Ultrasound. 2008; 17: 13-24.
  33. Никифоров В.С., Никитин А.Э., Яловец А.А., Свистов А.С. Стресс - эхокардиография с тканевой допплерографией: дополнительные возможности оценки функции сердечной мышцы. Кардиоваскулярн. терапия и профилактика. 2004; 3 (4); Прил. 2: 354.
  34. Agarwal R, Gosain P, Kirkpatrick J.N et al. Tissue Doppler imaging for diagnosis of coronary artery disease: a systematic review and meta - analysis. Cardiovasc Ultrasound 2012; 10: 47.
  35. Kadappu K.K, Thomas L. Tissue Doppler imaging in echocardiography: value and limitations. Heart Lung Circ 2015; 24 (3): 224-33.
  36. Медведев П.И., Алехин М.Н., Сидоренко Б.А. Диагностические возможности спекл - трекинг эхокардиографии у больных ишемической болезнью сердца. Кардиология. 2016; 56 (2): 79-84.
  37. Wierzbowska-Drabik K, Hamala P, Roszczyk N et al. Feasibility and correlation of standard 2D speckle tracking echocardiography and automated function imaging derived parameters of left ventricular function during dobutamine stress test. Int J Cardiovasc Imaging 2014; 30: 729-37.
  38. Никифоров В.С., Марсальская О.А., Новиков В.И. Эхокардиографическая оценка деформации миокарда в клинической практике. СПб.: КультИнформПресс, 2015.
  39. Никифоров В.С. Методы сердечно - сосудистой визуализации в диагностике жизнеспособного миокарда при ишемической болезни сердца. СПб.: КультИнформПресс, 2012.
  40. Klocke F.J, Baird M.G, Lorell B.H et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging -- executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003; 108 (11): 1404-18.
  41. Chen I.Y, Wu J.C. Cardiovascular molecular imaging: focus on clinical translation. Circulation 2011; 123 (4): 425-43.
  42. Лишманов Ю.Б., Чернов В.И., Минин С.М. Перфузионная сцинтиграфия миокарда. Рекомендации к выполнению исследования. Лучевая диагностика и терапия. 2010; 1: 97-102.
  43. Lalonde L, Ziadi M.C, Beanlands R. Cardiac positron emission tomography: current clinical practice. Cardiol Clin 2009; 27 (2): 237-55.
  44. Kajander S, Joutsiniemi E, Saraste M et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation 2010; 122: 603-13.
  45. Gaemperli O, Kaufmann P.A, Alkadhi H. Cardiac hybrid imaging. Eur J Nucl Med Mol Imaging 2014; 41 (Suppl. 1): S91-103.
  46. Lee W.W. Recent Advances in Nuclear Cardiology. Nucl Med Mol Imaging 2016; 50 (3): 196-206.
  47. Windecker S, Kolh P, Alfonso F et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio - Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35 (37): 2541-619.
  48. Genders T.S, Steyerberg E.W, Alkadhi H et al. A clinical prediction rule for the diagnosis of coronary artery disease: validation, updating, and extension. Eur Heart J 2011; 32: 1316-30.
  49. Gowda R.M, Khan I.A, Vasavada B.C et al. Reversible myocardial dysfunction: basics and evaluation. Int J Cardiol 2004; 97 (3): 349-53.
  50. Свистов А.С., Филиппов А.Е., Никифоров В.С., Никитин А.Э. Ишемическая болезнь сердца: диагностика и лечение жизнеспособного миокарда. СПб.: ВМедА, 2004.
  51. Yang T, Lu M.J, Sun H.S et al. Myocardial scar identified by magnetic resonance imaging can predict left ventricular functional improvement after coronary artery bypass grafting. PLoS One 2013; 8 (12): e81991.
  52. Никифоров B.C., Диденко М.В., Хубулава Г.Г., Свистов А.С. Ресинхронизация работы сердца - современный метод коррекции хронической сердечной недостаточности. Рос. кардиол. журн. 2005; (4): 87-93.
  53. Ponikowski P, Voors A.A, Anker S.D et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37 (27): 2129-200.
  54. Никифоров В.С., Лебедев Д.С., Свистов А.С. Роль эхокардиографических методик в оптимизации электрофизиологической ресинхронизации работы сердца у больных с хронической сердечной недостаточностью. Ультразвуковая и функциональная диагностика. 2006; 4: 118-28.
  55. Khan F.Z, Virdee M.S, Palmer C.R et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol 2012; 59: 1509-18.
  56. Bakos Z, Ostenfeld E, Markstad H et al. A comparison between radial strain evaluation by speckle - tracking echocardiography and cardiac magnetic resonance imaging, for assessment of suitable segments for left ventricular lead placement in cardiac resynchronization therapy. Europace 2014; 16 (12): 1779-86.
  57. Adelstein E.C, Tanaka H, Soman P et al. Impact of scar burden by single - photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011; 32: 93-103.
  58. Bose A, Kandala J, Upadhyay G.A et al. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol 2014; 25: 507-13.

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies